Angelalign Technology's (HKG:6699) subsidiary Wuxi EA Medical Instruments Technologies agreed to purchase certain raw materials from Shanghai Maxflex Medical Technology, a Wednesday bourse filing said.
The materials will be used for the production of clear aligners.
The annual caps set for the transaction are 30 million yuan for 2025, 42 million yuan for 2026, and 58.8 million yuan for 2027.